4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000130
Director sold 4,000 shares at an average $74.13 ($296,540)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2026-06-15 | Sale 10b5-1 | −3,801 | $74.10 | $281,651 | 53,051 | I |
| FOLETTA MARK G Director | 2026-06-15 | Sale 10b5-1 | −199 | $74.82 | $14,889 | 52,852 | I |
| Open-market sales · 4,000 sh · avg $74.13 · $296,540 | |||||||
Loading xslF345X06/wk-form4_1781728340.xml…